- Report
- March 2024
- 197 Pages
Global
From €3253EUR$3,374USD£2,782GBP
€3614EUR$3,749USD£3,091GBP
- Report
- February 2024
- 175 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- November 2023
- 146 Pages
Global
From €2409EUR$2,499USD£2,061GBP
- Report
- October 2023
- 178 Pages
Global
From €4724EUR$4,900USD£4,040GBP
- Report
- February 2024
- 120 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- June 2022
- 215 Pages
United States
From €2602EUR$2,699USD£2,225GBP
- Report
- June 2021
- 195 Pages
United States
From €2410EUR$2,500USD£2,061GBP
- Report
- January 2020
United States
From €1340EUR$1,390USD£1,146GBP
- Report
- October 2019
- 310 Pages
Global
From €3326EUR$3,450USD£2,845GBP
- Report
- June 2019
- 95 Pages
United States
From €1012EUR$1,050USD£866GBP
- Report
- June 2019
- 220 Pages
Global
From €2111EUR$2,190USD£1,806GBP
- Report
- May 2021
- 45 Pages
Global
€21210EUR$22,000USD£18,140GBP
- Drug Pipelines
- December 2018
- 145 Pages
Global
From €21210EUR$22,000USD£18,140GBP
- Report
- December 2018
- 14 Pages
Global
From €9641EUR$10,000USD£8,245GBP
- Report
- May 2019
- 171 Pages
Global
From €5177EUR$5,370USD£4,428GBP
Pneumovax is a vaccine used to protect against pneumococcal disease, a type of bacterial infection that can cause pneumonia, meningitis, and other serious illnesses. It is recommended for adults over the age of 65, as well as those with certain medical conditions. The vaccine is administered as a single dose, and is available in both injectable and intranasal forms.
The pneumococcal vaccine market is a growing segment of the overall vaccine market, with increasing demand for the vaccine due to its effectiveness in preventing serious illnesses. The market is expected to continue to grow in the coming years, driven by rising awareness of the importance of vaccination and increasing government initiatives to promote immunization.
The pneumococcal vaccine market is highly competitive, with several major players. These include Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, and AstraZeneca. Show Less Read more